| Clinical Pharmacogenetics Implementation Consortium guidelines for thiopurine methyltransferase genotype and thiopurine dosing MV Relling, EE Gardner, WJ Sandborn, K Schmiegelow, CH Pui, SW Yee, ... Clinical Pharmacology & Therapeutics 89 (3), 387-391, 2011 | 873 | 2011 |
| Clinical Pharmacogenetics Implementation Consortium Guidelines for Cytochrome P450–2C19 (CYP2C19) Genotype and Clopidogrel Therapy SA Scott, K Sangkuhl, EE Gardner, CM Stein, JS Hulot, JA Johnson, ... Clinical Pharmacology & Therapeutics 90 (2), 328-332, 2011 | 570 | 2011 |
| Macrophage ontogeny underlies differences in tumor-specific education in brain malignancies RL Bowman, F Klemm, L Akkari, SM Pyonteck, L Sevenich, DF Quail, ... Cell reports 17 (9), 2445-2459, 2016 | 539 | 2016 |
| Chemosensitive relapse in small cell lung cancer proceeds through an EZH2-SLFN11 axis EE Gardner, BH Lok, VE Schneeberger, P Desmeules, LA Miles, ... Cancer cell 31 (2), 286-299, 2017 | 408 | 2017 |
| CD47-blocking immunotherapies stimulate macrophage-mediated destruction of small-cell lung cancer K Weiskopf, NS Jahchan, PJ Schnorr, S Cristea, AM Ring, RL Maute, ... The Journal of clinical investigation 126 (7), 2610-2620, 2016 | 394 | 2016 |
| PARP Inhibitor Activity Correlates with SLFN11 Expression and Demonstrates Synergy with Temozolomide in Small Cell Lung Cancer BH Lok, EE Gardner, VE Schneeberger, A Ni, P Desmeules, N Rekhtman, ... Clinical Cancer Research 23 (2), 523-535, 2017 | 290 | 2017 |
| DNA methylation in small cell lung cancer defines distinct disease subtypes and correlates with high expression of EZH2 JT Poirier, EE Gardner, N Connis, AL Moreira, E De Stanchina, CL Hann, ... Oncogene 34 (48), 5869-5878, 2015 | 225 | 2015 |
| P-selectin is a nanotherapeutic delivery target in the tumor microenvironment Y Shamay, M Elkabets, H Li, J Shah, S Brook, F Wang, K Adler, E Baut, ... Science translational medicine 8 (345), 345ra87-345ra87, 2016 | 178 | 2016 |
| Noninvasive interrogation of DLL3 expression in metastatic small cell lung cancer SK Sharma, J Pourat, D Abdel-Atti, SD Carlin, A Piersigilli, AJ Bankovich, ... Cancer research 77 (14), 3931-3941, 2017 | 103 | 2017 |
| Anthrax toxin receptor 1 is the cellular receptor for Seneca Valley virus LA Miles, LN Burga, EE Gardner, M Bostina, JT Poirier, CM Rudin The Journal of clinical investigation 127 (8), 2957-2967, 2017 | 77 | 2017 |
| Rapamycin rescues ABT-737 efficacy in small cell lung cancer EE Gardner, N Connis, JT Poirier, L Cope, I Dobromilskaya, GL Gallia, ... Cancer research 74 (10), 2846-2856, 2014 | 66 | 2014 |
| Clinical Pharmacogenetics Implementation Consortium: Clinical Pharmacogenetics Implementation Consortium guidelines for thiopurine methyltransferase genotype and thiopurine dosing MV Relling, EE Gardner, WJ Sandborn, K Schmiegelow, CH Pui, SW Yee, ... Clin Pharmacol Ther 89 (3), 387-391, 2011 | 60 | 2011 |
| Combination treatment with ABT-737 and chloroquine in preclinical models of small cell lung cancer RL Zinn, EE Gardner, I Dobromilskaya, S Murphy, L Marchionni, CL Hann, ... Molecular cancer 12, 1-10, 2013 | 59 | 2013 |
| Quantitation of murine stroma and selective purification of the human tumor component of patient-derived xenografts for genomic analysis VE Schneeberger, V Allaj, EE Gardner, JT Poirier, CM Rudin PloS one 11 (9), e0160587, 2016 | 55 | 2016 |
| Clinical pharmacogenetics implementation consortium: clinical pharmacogenetics implementation consortium guidelines for cytochrome P450-2C19 (CYP2C19) genotype and clopidogrel … SA Scott, K Sangkuhl, EE Gardner, CM Stein, JS Hulot, JA Johnson, ... Clin Pharmacol Ther 90 (2), 328-332, 2011 | 52 | 2011 |
| ERK phosphorylation is predictive of resistance to IGF-1R inhibition in small cell lung cancer RL Zinn, EE Gardner, L Marchionni, SC Murphy, I Dobromilskaya, ... Molecular cancer therapeutics 12 (6), 1131-1139, 2013 | 45 | 2013 |
| Role of mTOR as an essential kinase in SCLC JA Kern, J Kim, DG Foster, R Mishra, EE Gardner, JT Poirier, C Rivard, ... Journal of Thoracic Oncology 15 (9), 1522-1534, 2020 | 15 | 2020 |
| Differential coupling of the human cannabinoid receptors hCB1R and hCB2R to the G-protein Gαi2β1γ2 K Nickl, EE Gardner, S Geiger, J Heilmann, R Seifert Neuroscience letters 447 (1), 68-72, 2008 | 12 | 2008 |
| Differential dynamics of extracellular and cytoplasmic domains in denatured states of rhodopsin A Dutta, C Altenbach, S Mangahas, N Yanamala, E Gardner, WL Hubbell, ... Biochemistry 53 (46), 7160-7169, 2014 | 9 | 2014 |
| The cytoplasmic rhodopsin-protein interface: potential for drug discovery N Yanamala, E Gardner, A Riciutti, J Klein-Seetharaman Current Drug Targets 13 (1), 3-14, 2012 | 9 | 2012 |
Charles RudinChief, Thoracic Oncology, Memorial Sloan Kettering Cancer CenterVerified email at mskcc.org
